Clinical sources and antimicrobial susceptibility of Prevotella timonensis at the university hospital of Montpellier, France

Salim Aberkane (1) , Baptiste Pradel (2, 3) , Yann Dumont (3, 4) , Alida C.M. Veloo

1 Pathogénèse et contrôle des infections chroniques (PCCI)
2 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
3 HSM - Hydrosciences Montpellier
4 UM - Université de Montpellier

We describe 84 clinical isolates of Prevotella timonensis recovered between January 2007 and November 2016 at the University Hospital of Montpellier. They were recovered from a variety of clinical samples, mostly of genital and wound origins. All isolates were isolated from a mixed aerobic and anaerobic microbiota. Antimicrobial susceptibility testing of 50 isolates showed 56% of beta-lactamase production and 40% of resistance to clindamycin. One strain was resistant to metronidazole.

Mots clés: Clinical relevance; Anaerobic bacteria; France; Prevotella timonensis; Antimicrobial resistance

Domaines: Bactériologie; Santé publique et épidémiologie

Salim Aberkane, Baptiste Pradel, Yann Dumont, Alida C.M. Veloo. Clinical sources and antimicrobial susceptibility of Prevotella timonensis at the university hospital of Montpellier, France. Anaerobe, 2018, 50, pp.19-21. ⟨10.1016/j.anaerobe.2018.01.002⟩. ⟨hal-01889881⟩